Malika Abdu Balkam
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Malika Abdu Balkam has a total of 2 co-authors. Here are the top co-authors by number of shared publications:
- Hussein Mussa Muafa
Department of Surgery, 21 September University for Medical and Applied Sciences, Sana’a, Yemen
8 shared publications - Mansoor Khalid Mansoor Ayish
Department of Pediatrics, Almansoor Polyclinic, Al-Hodaidah, Yemen
1 shared publication
Latest Publications
- Open Access
- 12 October 2026
- Published by Springer Nature in BMC Gastroenterology
Open abdomen closure strategies: a systematic review with stratified meta-analysis of primary fascial closure and narrative synthesis of timing, fistula, and hernia outcomes
Background: Open abdomen (OA) management can be lifesaving, but temporary abdominal closure strategies are heterogeneous and should not be treated as interchangeable. We evaluated closure-facilitating strategies in clinically coherent constructs, using meta-analysis only for comparable primary fascial-closure (PFC) comparisons and narrative synthesis for timing, fistula, and hernia outcomes. Methods: We reviewed adult OA studies identified in archived exports from PubMed/MEDLINE, Embase, Scopus, Web of Science Core Collection, and Cochrane CENTRAL. PRISMA 2020 was used as the reporting framework for this manuscript; however, the historical archive did not preserve a complete full-text retrieval/disposition log, reviewer-level evidence of independent duplicate screening, or independent duplicate risk-of-bias forms. The evidence flow was reconstructed from preserved database exports, citation-chain records, and report-level reconciliation, with unavailable process data explicitly reported as not reconstructable. Meta-analysis was restricted to independent two-arm studies with compatible intervention, comparator, PFC estimand, and extractable arm-level data. Random-effects models used REML with Hartung-Knapp adjustment. RoB 2, ROBINS-I, and QUIPS were used according to study design/question, and GRADE was applied to the quantitative PFC evidence. Results: The archived database exports contained 2,012 records. After deduplication, 845 unique database-derived records and 9 citation-chain records yielded 854 recoverable historical binary decisions (75 INCLUDE; 779 EXCLUDE). Report-level reconciliation removed 5 prior inclusion entries and identified 18 net additional eligible reports from archived source-export/evidence-map material, producing 88 eligible reports. Mesh-mediated traction plus NPWT was pooled in 2 studies (RR 1.80, 95% CI 1.00–3.26), and non-invasive traction/ABRA plus NPWT in 3 studies (RR 1.74, 95% CI 0.37–8.15; I² = 85.2%). Salamone 2018, Rasilainen 2020, Serclová 2012, and Balhara 2026 were individually audited but were not added to these pools because their estimands, denominators, comparators, extractable data, or cohort independence did not meet the pooling criteria. Fistula, hernia, and timing outcomes were synthesized narratively. Conclusions: Comparative data suggest that fascial traction may improve PFC, but the evidence is sparse, heterogeneous, and of very low certainty. No specific device or rigid timing threshold is supported by sufficiently certain evidence, and timing, fistula, and hernia findings remain narrative. The reconstructed nature of the historical screening and risk-of-bias archive, including unrecoverable full-text denominators and incomplete report-level search provenance for the 18 additional reports, further limits reproducibility and requires cautious interpretation. Registration: PROSPERO CRD420261286875.
- 12 October 2026
- Published by Springer Nature in BMC Gastroenterology
Open AccessOpen abdomen closure strategies: a systematic review with stratified meta-analysis of primary fascial closure and narrative synthesis of timing, fistula, and hernia outcomes
Background: Open abdomen (OA) management can be lifesaving, but temporary abdominal closure strategies are heterogeneous and should not be treated as interchangeable. We evaluated closure-facilitating strategies in clinically coherent constructs, using meta-analysis only for comparable primary fascial-closure (PFC) comparisons and narrative synthesis for timing, fistula, and hernia outcomes. Methods: We reviewed adult OA studies identified in archived exports from PubMed/MEDLINE, Embase, Scopus, Web of Science Core Collection, and Cochrane CENTRAL. PRISMA 2020 was used as the reporting framework for this manuscript; however, the historical archive did not preserve a complete full-text retrieval/disposition log, reviewer-level evidence of independent duplicate screening, or independent duplicate risk-of-bias forms. The evidence flow was reconstructed from preserved database exports, citation-chain records, and report-level reconciliation, with unavailable process data explicitly reported as not reconstructable. Meta-analysis was restricted to independent two-arm studies with compatible intervention, comparator, PFC estimand, and extractable arm-level data. Random-effects models used REML with Hartung-Knapp adjustment. RoB 2, ROBINS-I, and QUIPS were used according to study design/question, and GRADE was applied to the quantitative PFC evidence. Results: The archived database exports contained 2,012 records. After deduplication, 845 unique database-derived records and 9 citation-chain records yielded 854 recoverable historical binary decisions (75 INCLUDE; 779 EXCLUDE). Report-level reconciliation removed 5 prior inclusion entries and identified 18 net additional eligible reports from archived source-export/evidence-map material, producing 88 eligible reports. Mesh-mediated traction plus NPWT was pooled in 2 studies (RR 1.80, 95% CI 1.00–3.26), and non-invasive traction/ABRA plus NPWT in 3 studies (RR 1.74, 95% CI 0.37–8.15; I² = 85.2%). Salamone 2018, Rasilainen 2020, Serclová 2012, and Balhara 2026 were individually audited but were not added to these pools because their estimands, denominators, comparators, extractable data, or cohort independence did not meet the pooling criteria. Fistula, hernia, and timing outcomes were synthesized narratively. Conclusions: Comparative data suggest that fascial traction may improve PFC, but the evidence is sparse, heterogeneous, and of very low certainty. No specific device or rigid timing threshold is supported by sufficiently certain evidence, and timing, fistula, and hernia findings remain narrative. The reconstructed nature of the historical screening and risk-of-bias archive, including unrecoverable full-text denominators and incomplete report-level search provenance for the 18 additional reports, further limits reproducibility and requires cautious interpretation. Registration: PROSPERO CRD420261286875.
- Open Access
- 14 April 2026
- Published by MDPI AG in Preprints.org
Robotic-Assisted, Video-Assisted, and Open Sleeve Lobectomy After Neoadjuvant Therapy for Non-Small Cell Lung Cancer: A Systematic Review and Network Meta-Analysis
Background: Neoadjuvant therapy, particularly chemoimmunotherapy, has transformed the management of locally advanced non-small cell lung cancer (NSCLC). However, treatment-induced hilar fibrosis and tissue adhesions may increase the complexity of subsequent surgical resection, especially for technically demanding procedures such as sleeve lobectomy. The optimal surgical approach—robotic-assisted thoracic surgery (RATS), video-assisted thoracoscopic surgery (VATS), or open thoracotomy—remains uncertain in this setting. Methods: A systematic review and network meta-analysis (NMA) were conducted in accordance with PRISMA and PRISMA-NMA guidelines. PubMed, Embase, Cochrane Library, and Web of Science were searched from inception to present. Studies comparing RATS, VATS, and open sleeve lobectomy in NSCLC patients following neoadjuvant therapy were included, while mixed cohorts were excluded to ensure data homogeneity. Primary outcomes included postoperative complications, 30-day mortality, operative time, and intraoperative blood loss. Secondary outcomes included R0 resection rate, lymph node harvest, conversion rate, bronchial anastomosis time, and length of hospital stay. A frequentist network meta-analysis was performed. Odds ratios (OR) and mean differences (MD) with 95% confidence intervals (CI) were calculated. Heterogeneity was assessed using I² statistics, and treatment ranking was performed using SUCRA. Results: Five retrospective studies comprising 175 patients were included (RATS: 39, VATS: 114, Open: 22). Postoperative complications were comparable across approaches, with no statistically significant differences between RATS and VATS (OR 1.35, 95% CI 0.38–4.7), RATS and Open (OR 1.9, 95% CI 0.25–13.8), or VATS and Open (OR 0.22, 95% CI 0.03–1.6), although a trend favoring VATS was observed. Mortality rates were low and did not significantly differ between groups. Minimally invasive approaches (RATS and VATS) were associated with reduced intraoperative blood loss (MD approximately −70 to −100 mL) and shorter hospital stay (reduction of ~1–3 days) compared to open thoracotomy. RATS demonstrated a trend toward higher lymph node harvest (mean difference ~2–3 nodes) and showed a 0% conversion rate, whereas VATS conversion ranged from 4.7% to 30%. SUCRA ranking indicated that RATS had the highest probability of being the optimal approach (0.78), followed by VATS (0.64) and open thoracotomy (0.21). Heterogeneity was low to moderate (I² 0–40%), with no significant inconsistency detected. Conclusions: Minimally invasive sleeve lobectomy, including both RATS and VATS, appears to be safe and feasible for NSCLC patients following neoadjuvant therapy. RATS demonstrated favorable trends in technical outcomes, including lower conversion rates and improved lymph node harvest, and ranked highest in SUCRA analysis. However, given the limited sample size and observational nature of the included studies, these findings should be interpreted with caution. Further large-scale prospective and randomized studies are required to determine the optimal surgical approach in this setting. Systematic Review Registration: PROSPERO CRD420261358976.
- 14 April 2026
- Published by MDPI AG in Preprints.org
Open AccessRobotic-Assisted, Video-Assisted, and Open Sleeve Lobectomy After Neoadjuvant Therapy for Non-Small Cell Lung Cancer: A Systematic Review and Network Meta-Analysis
Background: Neoadjuvant therapy, particularly chemoimmunotherapy, has transformed the management of locally advanced non-small cell lung cancer (NSCLC). However, treatment-induced hilar fibrosis and tissue adhesions may increase the complexity of subsequent surgical resection, especially for technically demanding procedures such as sleeve lobectomy. The optimal surgical approach—robotic-assisted thoracic surgery (RATS), video-assisted thoracoscopic surgery (VATS), or open thoracotomy—remains uncertain in this setting. Methods: A systematic review and network meta-analysis (NMA) were conducted in accordance with PRISMA and PRISMA-NMA guidelines. PubMed, Embase, Cochrane Library, and Web of Science were searched from inception to present. Studies comparing RATS, VATS, and open sleeve lobectomy in NSCLC patients following neoadjuvant therapy were included, while mixed cohorts were excluded to ensure data homogeneity. Primary outcomes included postoperative complications, 30-day mortality, operative time, and intraoperative blood loss. Secondary outcomes included R0 resection rate, lymph node harvest, conversion rate, bronchial anastomosis time, and length of hospital stay. A frequentist network meta-analysis was performed. Odds ratios (OR) and mean differences (MD) with 95% confidence intervals (CI) were calculated. Heterogeneity was assessed using I² statistics, and treatment ranking was performed using SUCRA. Results: Five retrospective studies comprising 175 patients were included (RATS: 39, VATS: 114, Open: 22). Postoperative complications were comparable across approaches, with no statistically significant differences between RATS and VATS (OR 1.35, 95% CI 0.38–4.7), RATS and Open (OR 1.9, 95% CI 0.25–13.8), or VATS and Open (OR 0.22, 95% CI 0.03–1.6), although a trend favoring VATS was observed. Mortality rates were low and did not significantly differ between groups. Minimally invasive approaches (RATS and VATS) were associated with reduced intraoperative blood loss (MD approximately −70 to −100 mL) and shorter hospital stay (reduction of ~1–3 days) compared to open thoracotomy. RATS demonstrated a trend toward higher lymph node harvest (mean difference ~2–3 nodes) and showed a 0% conversion rate, whereas VATS conversion ranged from 4.7% to 30%. SUCRA ranking indicated that RATS had the highest probability of being the optimal approach (0.78), followed by VATS (0.64) and open thoracotomy (0.21). Heterogeneity was low to moderate (I² 0–40%), with no significant inconsistency detected. Conclusions: Minimally invasive sleeve lobectomy, including both RATS and VATS, appears to be safe and feasible for NSCLC patients following neoadjuvant therapy. RATS demonstrated favorable trends in technical outcomes, including lower conversion rates and improved lymph node harvest, and ranked highest in SUCRA analysis. However, given the limited sample size and observational nature of the included studies, these findings should be interpreted with caution. Further large-scale prospective and randomized studies are required to determine the optimal surgical approach in this setting. Systematic Review Registration: PROSPERO CRD420261358976.
- Open Access
- 9 April 2026
- Published by Springer Nature in BMC Surgery
- Vol. 26 (1)
Robotic-assisted versus laparoscopic surgery for colorectal resection in oncologic surgery: a systematic review and meta-analysis of randomized controlled trials
Background: Robotic-assisted surgery (RAS) is increasingly used for colorectal cancer (CRC), but its clinical and oncologic advantages over conventional laparoscopy (LS) remain uncertain. Prior meta-analyses (e.g., Huang et al., Front Oncol 13;1273378, 2023; Zou et al., BMC Surg 25;86, 2025) have included overlapping RCTs but vary in methodology, scope, and analytical transparency. This review aims to provide an updated, independently re-analyzed synthesis of RCTs published from 2015 to 2025, with full PRISMA compliance, explicit analytic reproducibility, and expanded evaluation of bias and evidence certainty. Methods: A systematic review and meta-analysis was conducted according to PRISMA guidelines. The protocol was retrospectively registered in PROSPERO (Registration ID: CRD420251237158 ). PubMed, Embase, and Cochrane CENTRAL were searched (January 1, 2015–January 31, 2025). Full reproducible search strings, PICOS criteria, and inclusion/exclusion rules were predefined. Only RCTs comparing RAS vs. LS for malignant colorectal disease were included. Data extraction was performed independently by two reviewers. Meta-analyses used DerSimonian–Laird random-effects models; standardized procedures were applied for converting medians/IQRs into means/SDs and for continuity corrections in zero-event trials. Risk of bias was assessed using Cochrane RoB 2.0, and evidence certainty was graded using GRADE. Results: A total of 12 RCTs encompassing 3,107 patients met the inclusion criteria. RAS resulted in significantly lower conversion-to-open rates (OR 0.42; 95% CI 0.28–0.63; I²=18%) compared with LS. Operative time was consistently longer with RAS (MD + 23.8 min; 95% CI 14.2–33.4; I²=67%). Overall postoperative complications (Clavien–Dindo ≥ II) were comparable (OR 0.91; 95% CI 0.76–1.13; I²=22%). Length of stay showed a small but significant reduction with RAS (MD − 0.8 days; 95% CI − 1.3 to − 0.2; I²=49%). Pathologic outcomes showed lower circumferential resection margin (CRM) positivity with RAS (OR 0.59; 95% CI 0.41–0.85). Lymph node retrieval was slightly higher with RAS (MD + 0.71 nodes; 95% CI 0.25–1.18). Distal margins and TME completeness were equivalent. No RCT reported mature long-term oncologic outcomes; evidence remains limited to short-term surrogates. Conclusions: In contemporary RCTs, RAS provides fewer conversions and slightly better pathologic surrogates, while maintaining similar morbidity compared to LS. The main trade-off remains longer operative time and higher resource use. True oncologic equivalence cannot be confirmed until long-term RCT data mature. Advanced imaging (e.g., SOMATOM Force CT), age-specific MIS evidence, and the emergence of endoluminal robotic systems are likely to shape future refinements in technique and patient selection.
- 9 April 2026
- Published by Springer Nature in BMC Surgery
- Vol. 26 (1)
Open AccessRobotic-assisted versus laparoscopic surgery for colorectal resection in oncologic surgery: a systematic review and meta-analysis of randomized controlled trials
Background: Robotic-assisted surgery (RAS) is increasingly used for colorectal cancer (CRC), but its clinical and oncologic advantages over conventional laparoscopy (LS) remain uncertain. Prior meta-analyses (e.g., Huang et al., Front Oncol 13;1273378, 2023; Zou et al., BMC Surg 25;86, 2025) have included overlapping RCTs but vary in methodology, scope, and analytical transparency. This review aims to provide an updated, independently re-analyzed synthesis of RCTs published from 2015 to 2025, with full PRISMA compliance, explicit analytic reproducibility, and expanded evaluation of bias and evidence certainty. Methods: A systematic review and meta-analysis was conducted according to PRISMA guidelines. The protocol was retrospectively registered in PROSPERO (Registration ID: CRD420251237158 ). PubMed, Embase, and Cochrane CENTRAL were searched (January 1, 2015–January 31, 2025). Full reproducible search strings, PICOS criteria, and inclusion/exclusion rules were predefined. Only RCTs comparing RAS vs. LS for malignant colorectal disease were included. Data extraction was performed independently by two reviewers. Meta-analyses used DerSimonian–Laird random-effects models; standardized procedures were applied for converting medians/IQRs into means/SDs and for continuity corrections in zero-event trials. Risk of bias was assessed using Cochrane RoB 2.0, and evidence certainty was graded using GRADE. Results: A total of 12 RCTs encompassing 3,107 patients met the inclusion criteria. RAS resulted in significantly lower conversion-to-open rates (OR 0.42; 95% CI 0.28–0.63; I²=18%) compared with LS. Operative time was consistently longer with RAS (MD + 23.8 min; 95% CI 14.2–33.4; I²=67%). Overall postoperative complications (Clavien–Dindo ≥ II) were comparable (OR 0.91; 95% CI 0.76–1.13; I²=22%). Length of stay showed a small but significant reduction with RAS (MD − 0.8 days; 95% CI − 1.3 to − 0.2; I²=49%). Pathologic outcomes showed lower circumferential resection margin (CRM) positivity with RAS (OR 0.59; 95% CI 0.41–0.85). Lymph node retrieval was slightly higher with RAS (MD + 0.71 nodes; 95% CI 0.25–1.18). Distal margins and TME completeness were equivalent. No RCT reported mature long-term oncologic outcomes; evidence remains limited to short-term surrogates. Conclusions: In contemporary RCTs, RAS provides fewer conversions and slightly better pathologic surrogates, while maintaining similar morbidity compared to LS. The main trade-off remains longer operative time and higher resource use. True oncologic equivalence cannot be confirmed until long-term RCT data mature. Advanced imaging (e.g., SOMATOM Force CT), age-specific MIS evidence, and the emergence of endoluminal robotic systems are likely to shape future refinements in technique and patient selection.
- Open Access
- 22 January 2026
- Published by Springer Nature in Research Square
Early (≤7-Day) Definitive Fascial Closure After Open Abdomen Reduces Long-Term Morbidity: A Systematic Review and Meta-analysis
Background: Open abdomen (OA) management remains a life-saving strategy in trauma, intra-abdominal sepsis, and abdominal compartment syndrome. Failure to achieve definitive fascial closure (DFC) during the index hospitalization is strongly associated with long-term morbidity, particularly incisional hernia and entero-atmospheric fistula (EAF). While early closure has been associated with higher primary closure rates, its impact on durable, patient-centered outcomes has not been consistently evaluated. Objective: To determine whether early (≤ 7 days) versus delayed definitive fascial closure after open abdomen management is associated with differences in long-term morbidity and clinically relevant secondary outcomes. Methods: A systematic review and meta-analysis was conducted in accordance with PRISMA 2020 guidelines. MEDLINE, Embase, Scopus, Web of Science, and Cochrane CENTRAL were searched from inception to January 2026. Comparative studies involving adult patients undergoing OA management were included. Primary outcomes were long-term incisional hernia and EAF/ECF. Random-effects meta-analysis was performed, with predefined subgroup and sensitivity analyses. Results: Nine studies encompassing 1,842 patients were included. Early closure was associated with a significantly lower risk of incisional hernia (18.6% vs 34.9%; RR 0.56, 95% CI 0.44–0.71) and EAF (6.2% vs 11.8%; RR 0.53, 95% CI 0.35–0.81). Early closure also increased the likelihood of primary fascial closure (RR 1.42, 95% CI 1.25–1.61) without increasing short-term mortality. Conclusion: Definitive fascial closure within ≤ 7 days after open abdomen management is associated with substantially improved long-term abdominal wall outcomes without compromising survival. Early closure should be considered a key therapeutic target in contemporary OA management.
- 22 January 2026
- Published by Springer Nature in Research Square
Open AccessEarly (≤7-Day) Definitive Fascial Closure After Open Abdomen Reduces Long-Term Morbidity: A Systematic Review and Meta-analysis
Background: Open abdomen (OA) management remains a life-saving strategy in trauma, intra-abdominal sepsis, and abdominal compartment syndrome. Failure to achieve definitive fascial closure (DFC) during the index hospitalization is strongly associated with long-term morbidity, particularly incisional hernia and entero-atmospheric fistula (EAF). While early closure has been associated with higher primary closure rates, its impact on durable, patient-centered outcomes has not been consistently evaluated. Objective: To determine whether early (≤ 7 days) versus delayed definitive fascial closure after open abdomen management is associated with differences in long-term morbidity and clinically relevant secondary outcomes. Methods: A systematic review and meta-analysis was conducted in accordance with PRISMA 2020 guidelines. MEDLINE, Embase, Scopus, Web of Science, and Cochrane CENTRAL were searched from inception to January 2026. Comparative studies involving adult patients undergoing OA management were included. Primary outcomes were long-term incisional hernia and EAF/ECF. Random-effects meta-analysis was performed, with predefined subgroup and sensitivity analyses. Results: Nine studies encompassing 1,842 patients were included. Early closure was associated with a significantly lower risk of incisional hernia (18.6% vs 34.9%; RR 0.56, 95% CI 0.44–0.71) and EAF (6.2% vs 11.8%; RR 0.53, 95% CI 0.35–0.81). Early closure also increased the likelihood of primary fascial closure (RR 1.42, 95% CI 1.25–1.61) without increasing short-term mortality. Conclusion: Definitive fascial closure within ≤ 7 days after open abdomen management is associated with substantially improved long-term abdominal wall outcomes without compromising survival. Early closure should be considered a key therapeutic target in contemporary OA management.
- Open Access
- 16 January 2026
- Published by Springer Nature in Research Square
Outcomes of Damage Control Laparotomy in Resource-Limited Settings: A Systematic Review and Meta-analysis
Background Damage control laparotomy (DCL) is an established life-saving strategy for patients with severe abdominal trauma or profound physiological derangement. The majority of evidence supporting its use originates from high-income, well-resourced trauma systems. In contrast, the effectiveness, feasibility, and complications of DCL in resource-limited settings (RLS), including low- and middle-income countries (LMICs) and hospitals with constrained intensive care capacity, have not been comprehensively synthesized [1, 2]. Methods This systematic review and meta-analysis was conducted in accordance with PRISMA 2020 guidelines. The study protocol was prospectively registered in PROSPERO (CRD420261282585). We searched PubMed/MEDLINE, Embase, Scopus, Web of Science, and Cochrane CENTRAL from inception to 10 January 2026, supplemented by grey-literature searches. Eligible studies reported clinical outcomes of DCL or open-abdomen management performed in resource-limited hospitals. Two reviewers independently screened studies, extracted data, and assessed risk of bias using ROBINS-I or RoB 2.0, as appropriate. The primary outcome was in-hospital mortality. Secondary outcomes included intensive care unit (ICU) length of stay, hospital length of stay, definitive fascial closure, entero-atmospheric fistula (EAF), surgical site infection, ventilator days, and re-operation rates. Random-effects meta-analyses were planned where data permitted [2, 3, 4]. Results The available literature from RLS was heterogeneous and predominantly comprised retrospective single-centre cohorts and case series from tertiary hospitals in LMICs. Reported in-hospital mortality following damage control laparotomy ranged from approximately 29% to 55%, reflecting substantial heterogeneity in patient severity, injury mechanism, and institutional capacity. Physiological derangement on admission, high injury severity scores, major vascular injury, and large transfusion requirements were consistently associated with worse outcomes. Temporary abdominal closure techniques varied according to resource availability, most commonly including the Bogotá bag, improvised vacuum systems, and, where available, commercial negative-pressure wound therapy. Primary fascial closure and complication rates differed substantially between studies. Quantitative pooling was limited by inconsistent outcome definitions and incomplete reporting in several series [2, 5, 6]. Conclusion Damage control laparotomy is widely practiced in resource-limited settings and can be life-saving when supported by adequate resuscitation and critical care resources. However, outcomes remain highly variable and strongly dependent on physiological status at presentation and institutional capacity. Standardised outcome reporting and prospective, multicentre data from RLS are urgently needed to generate more reliable pooled estimates and to guide context-appropriate practice [3, 7].
- 16 January 2026
- Published by Springer Nature in Research Square
Open AccessOutcomes of Damage Control Laparotomy in Resource-Limited Settings: A Systematic Review and Meta-analysis
Background Damage control laparotomy (DCL) is an established life-saving strategy for patients with severe abdominal trauma or profound physiological derangement. The majority of evidence supporting its use originates from high-income, well-resourced trauma systems. In contrast, the effectiveness, feasibility, and complications of DCL in resource-limited settings (RLS), including low- and middle-income countries (LMICs) and hospitals with constrained intensive care capacity, have not been comprehensively synthesized [1, 2]. Methods This systematic review and meta-analysis was conducted in accordance with PRISMA 2020 guidelines. The study protocol was prospectively registered in PROSPERO (CRD420261282585). We searched PubMed/MEDLINE, Embase, Scopus, Web of Science, and Cochrane CENTRAL from inception to 10 January 2026, supplemented by grey-literature searches. Eligible studies reported clinical outcomes of DCL or open-abdomen management performed in resource-limited hospitals. Two reviewers independently screened studies, extracted data, and assessed risk of bias using ROBINS-I or RoB 2.0, as appropriate. The primary outcome was in-hospital mortality. Secondary outcomes included intensive care unit (ICU) length of stay, hospital length of stay, definitive fascial closure, entero-atmospheric fistula (EAF), surgical site infection, ventilator days, and re-operation rates. Random-effects meta-analyses were planned where data permitted [2, 3, 4]. Results The available literature from RLS was heterogeneous and predominantly comprised retrospective single-centre cohorts and case series from tertiary hospitals in LMICs. Reported in-hospital mortality following damage control laparotomy ranged from approximately 29% to 55%, reflecting substantial heterogeneity in patient severity, injury mechanism, and institutional capacity. Physiological derangement on admission, high injury severity scores, major vascular injury, and large transfusion requirements were consistently associated with worse outcomes. Temporary abdominal closure techniques varied according to resource availability, most commonly including the Bogotá bag, improvised vacuum systems, and, where available, commercial negative-pressure wound therapy. Primary fascial closure and complication rates differed substantially between studies. Quantitative pooling was limited by inconsistent outcome definitions and incomplete reporting in several series [2, 5, 6]. Conclusion Damage control laparotomy is widely practiced in resource-limited settings and can be life-saving when supported by adequate resuscitation and critical care resources. However, outcomes remain highly variable and strongly dependent on physiological status at presentation and institutional capacity. Standardised outcome reporting and prospective, multicentre data from RLS are urgently needed to generate more reliable pooled estimates and to guide context-appropriate practice [3, 7].
- Open Access
- 30 December 2025
- Published by MDPI AG in Preprints.org
Post-Streptococcal Glomerulonephritis Presenting with Acute Pulmonary Edema and Critical Hyperkalemia: A Rare Pediatric Case from Yemen
Background: Post-streptococcal glomerulonephritis (PSGN) is a common cause of acute nephritic syndrome in children. Rarely, it may result in life-threatening complications, including acute pulmonary edema and critical hyperkalemia. Case Presentation: We report a 10-year-old Yemeni girl (25 kg) presenting with severe respiratory distress, irritability, and generalized pitting edema. Laboratory tests confirmed PSGN with markedly reduced complement C3 (42.2 mg/dL) and nephritic urine sediment containing numerous red blood cells and casts. The patient developed critical hyperkalemia (7.0 mmol/L) and acute pulmonary edema, requiring urgent intubation and mechanical ventilation using pressure-controlled mandatory ventilation (P-CMV). Management: Aggressive fluid mobilization and electrolyte stabilization were initiated. High-dose intravenous furosemide (4 mg/kg/day), renal-dose dopamine (5 μg/kg/min), and potassium-lowering interventions were applied. Morphine sedation (0.1 mg/kg/dose) was administered every 4 hours during the first 24 hours, then every 8 hours for 12 additional hours, followed by withdrawal prior to extubation. Morphine effectively controlled irritability and optimized patient–ventilator synchronization. The patient produced 1700 mL urine in 17 hours, demonstrating a strong diuretic response. Conclusion: Early recognition of severe extra-renal complications in PSGN is critical. Intensive supportive care—including mechanical ventilation, meticulous fluid and electrolyte management, and appropriate sedation—is essential for survival in cases of acute pulmonary edema and critical hyperkalemia.
- 30 December 2025
- Published by MDPI AG in Preprints.org
Open AccessPost-Streptococcal Glomerulonephritis Presenting with Acute Pulmonary Edema and Critical Hyperkalemia: A Rare Pediatric Case from Yemen
Background: Post-streptococcal glomerulonephritis (PSGN) is a common cause of acute nephritic syndrome in children. Rarely, it may result in life-threatening complications, including acute pulmonary edema and critical hyperkalemia. Case Presentation: We report a 10-year-old Yemeni girl (25 kg) presenting with severe respiratory distress, irritability, and generalized pitting edema. Laboratory tests confirmed PSGN with markedly reduced complement C3 (42.2 mg/dL) and nephritic urine sediment containing numerous red blood cells and casts. The patient developed critical hyperkalemia (7.0 mmol/L) and acute pulmonary edema, requiring urgent intubation and mechanical ventilation using pressure-controlled mandatory ventilation (P-CMV). Management: Aggressive fluid mobilization and electrolyte stabilization were initiated. High-dose intravenous furosemide (4 mg/kg/day), renal-dose dopamine (5 μg/kg/min), and potassium-lowering interventions were applied. Morphine sedation (0.1 mg/kg/dose) was administered every 4 hours during the first 24 hours, then every 8 hours for 12 additional hours, followed by withdrawal prior to extubation. Morphine effectively controlled irritability and optimized patient–ventilator synchronization. The patient produced 1700 mL urine in 17 hours, demonstrating a strong diuretic response. Conclusion: Early recognition of severe extra-renal complications in PSGN is critical. Intensive supportive care—including mechanical ventilation, meticulous fluid and electrolyte management, and appropriate sedation—is essential for survival in cases of acute pulmonary edema and critical hyperkalemia.
- Open Access
- 12 December 2025
- Published by MDPI AG in Preprints.org
Robotic-Assisted Versus Laparoscopic Surgery for Colorectal Resection in Oncologic Surgery: A Systematic Review and Meta-Analysis of Randomized Controlled Trials (2025)
Background: Robotic-assisted surgery (RAS) is increasingly used for colorectal cancer (CRC), but its clinical and oncologic advantages over conventional laparoscopy (LS) remain uncertain. Prior meta-analyses have included overlapping RCTs but vary in methodology, scope, and analytical transparency. This review aims to provide an updated, independently re-analyzed synthesis of RCTs published from 2015–2025, with full PRISMA compliance, explicit analytic reproducibility, and expanded evaluation of bias and evidence certainty. Methods: A systematic review and meta-analysis was conducted according to PRISMA guidelines. The protocol was retrospectively registered in PROSPERO (Registration ID: CRD420251237158). PubMed, Embase, and Cochrane CENTRAL were searched (January 1, 2015–January 31, 2025). Full reproducible search strings, PICOS criteria, and inclusion/exclusion rules were predefined. Only RCTs comparing RAS vs LS for malignant colorectal disease were included. Data extraction was performed independently by two reviewers. Meta-analyses used DerSimonian–Laird random-effects models; standardized procedures were applied for converting medians/IQRs into means/SDs and for continuity corrections in zero-event trials. Risk of bias was assessed using Cochrane RoB 2.0, and evidence certainty was graded using GRADE. Results: A total of 12 RCTs encompassing 3,107 patients met the inclusion criteria. RAS resulted in significantly lower conversion-to-open rates (OR 0.42; 95% CI 0.28–0.63; I²=18%) compared with LS. Operative time was consistently longer with RAS (MD +23.8 minutes; 95% CI 14.2–33.4; I²=67%). Overall postoperative complications (Clavien–Dindo ≥II) were comparable (OR 0.91; 95% CI 0.76–1.13; I²=22%). Length of stay showed a small but significant reduction with RAS (MD −0.8 days; 95% CI −1.3 to −0.2; I²=49%). Pathologic outcomes showed lower circumferential resection margin (CRM) positivity with RAS (OR 0.59; 95% CI 0.41–0.85). Lymph node retrieval was slightly higher with RAS (MD +0.71 nodes; 95% CI 0.25–1.18). Distal margins and TME completeness were equivalent. No RCT reported mature long-term oncologic outcomes; evidence remains limited to short-term surrogates. Conclusions: In contemporary RCTs, RAS provides fewer conversions and slightly better pathologic surrogates, while maintaining similar morbidity compared to LS. The main trade-off remains longer operative time and higher resource use. True oncologic equivalence cannot be confirmed until long-term RCT data mature. Advanced imaging (e.g., SOMATOM Force CT), age-specific MIS evidence, and the emergence of endoluminal robotic systems are likely to shape future refinements in technique and patient selection.
- 12 December 2025
- Published by MDPI AG in Preprints.org
Open AccessRobotic-Assisted Versus Laparoscopic Surgery for Colorectal Resection in Oncologic Surgery: A Systematic Review and Meta-Analysis of Randomized Controlled Trials (2025)
Background: Robotic-assisted surgery (RAS) is increasingly used for colorectal cancer (CRC), but its clinical and oncologic advantages over conventional laparoscopy (LS) remain uncertain. Prior meta-analyses have included overlapping RCTs but vary in methodology, scope, and analytical transparency. This review aims to provide an updated, independently re-analyzed synthesis of RCTs published from 2015–2025, with full PRISMA compliance, explicit analytic reproducibility, and expanded evaluation of bias and evidence certainty. Methods: A systematic review and meta-analysis was conducted according to PRISMA guidelines. The protocol was retrospectively registered in PROSPERO (Registration ID: CRD420251237158). PubMed, Embase, and Cochrane CENTRAL were searched (January 1, 2015–January 31, 2025). Full reproducible search strings, PICOS criteria, and inclusion/exclusion rules were predefined. Only RCTs comparing RAS vs LS for malignant colorectal disease were included. Data extraction was performed independently by two reviewers. Meta-analyses used DerSimonian–Laird random-effects models; standardized procedures were applied for converting medians/IQRs into means/SDs and for continuity corrections in zero-event trials. Risk of bias was assessed using Cochrane RoB 2.0, and evidence certainty was graded using GRADE. Results: A total of 12 RCTs encompassing 3,107 patients met the inclusion criteria. RAS resulted in significantly lower conversion-to-open rates (OR 0.42; 95% CI 0.28–0.63; I²=18%) compared with LS. Operative time was consistently longer with RAS (MD +23.8 minutes; 95% CI 14.2–33.4; I²=67%). Overall postoperative complications (Clavien–Dindo ≥II) were comparable (OR 0.91; 95% CI 0.76–1.13; I²=22%). Length of stay showed a small but significant reduction with RAS (MD −0.8 days; 95% CI −1.3 to −0.2; I²=49%). Pathologic outcomes showed lower circumferential resection margin (CRM) positivity with RAS (OR 0.59; 95% CI 0.41–0.85). Lymph node retrieval was slightly higher with RAS (MD +0.71 nodes; 95% CI 0.25–1.18). Distal margins and TME completeness were equivalent. No RCT reported mature long-term oncologic outcomes; evidence remains limited to short-term surrogates. Conclusions: In contemporary RCTs, RAS provides fewer conversions and slightly better pathologic surrogates, while maintaining similar morbidity compared to LS. The main trade-off remains longer operative time and higher resource use. True oncologic equivalence cannot be confirmed until long-term RCT data mature. Advanced imaging (e.g., SOMATOM Force CT), age-specific MIS evidence, and the emergence of endoluminal robotic systems are likely to shape future refinements in technique and patient selection.
- Open Access
- 11 November 2025
- Published by MDPI AG in Preprints.org
Restrictive vs Liberal Fluid Strategy for Initial Resuscitation in Sepsis and Septic Shock: A Systematic Review and Meta-Analysis (2025)
Background: Fluid resuscitation is a cornerstone in the management of sepsis and septic shock, yet the optimal strategy remains controversial. Liberal strategies may restore tissue perfusion quickly but can increase the risk of fluid overload, pulmonary edema, and organ dysfunction. Restrictive strategies aim to limit fluid accumulation while maintaining adequate perfusion. Objective: This systematic review and meta-analysis aims to synthesize randomized controlled trials (RCTs) comparing restrictive versus liberal fluid strategies in adults with sepsis or septic shock, focusing on mortality, ICU outcomes, renal outcomes, and fluid balance. Methods: A comprehensive search was conducted in PubMed, Scopus, Web of Science, and Cochrane Library up to October 2025. RCTs comparing restrictive versus liberal fluid strategies in adult patients were included. Data were extracted for mortality, ICU length of stay, ventilator-free days, renal replacement therapy (RRT), and cumulative fluid balance. Risk of bias was assessed using Cochrane RoB 2, and evidence certainty using GRADE. Meta-analysis was performed using random-effects models. Results: Twelve RCTs comprising 8,743 patients were included. Restrictive strategies reduced cumulative fluid balance and showed trends toward fewer ventilator and ICU days. Mortality differences between groups were not statistically significant. Conclusions: Restrictive fluid resuscitation is safe and may reduce complications associated with fluid overload without adversely affecting survival. Individualized, hemodynamic-guided fluid management remains recommended.
- 11 November 2025
- Published by MDPI AG in Preprints.org
Open AccessRestrictive vs Liberal Fluid Strategy for Initial Resuscitation in Sepsis and Septic Shock: A Systematic Review and Meta-Analysis (2025)
Background: Fluid resuscitation is a cornerstone in the management of sepsis and septic shock, yet the optimal strategy remains controversial. Liberal strategies may restore tissue perfusion quickly but can increase the risk of fluid overload, pulmonary edema, and organ dysfunction. Restrictive strategies aim to limit fluid accumulation while maintaining adequate perfusion. Objective: This systematic review and meta-analysis aims to synthesize randomized controlled trials (RCTs) comparing restrictive versus liberal fluid strategies in adults with sepsis or septic shock, focusing on mortality, ICU outcomes, renal outcomes, and fluid balance. Methods: A comprehensive search was conducted in PubMed, Scopus, Web of Science, and Cochrane Library up to October 2025. RCTs comparing restrictive versus liberal fluid strategies in adult patients were included. Data were extracted for mortality, ICU length of stay, ventilator-free days, renal replacement therapy (RRT), and cumulative fluid balance. Risk of bias was assessed using Cochrane RoB 2, and evidence certainty using GRADE. Meta-analysis was performed using random-effects models. Results: Twelve RCTs comprising 8,743 patients were included. Restrictive strategies reduced cumulative fluid balance and showed trends toward fewer ventilator and ICU days. Mortality differences between groups were not statistically significant. Conclusions: Restrictive fluid resuscitation is safe and may reduce complications associated with fluid overload without adversely affecting survival. Individualized, hemodynamic-guided fluid management remains recommended.